Live Quote · NASDAQRAPPHealthcare· Biotechnology

Rapport Therapeutics, Inc. Common Stock

$23.16▼ 1.82%($-0.43)
MKT CAP $1.11BNEXT EARNINGS Mar 9, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
60
Valuation
40
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RAPP research report →

Analyst Price Target
$69.10+198.4% vs. today

Range $47 – $91

Analyst RatingBuy
8 Buy0 Hold0 Sell

Price Chart

-13.74% · this period
$52.50$37.50$22.50Nov 20May 26Nov 20
52-Week Range4% of range
Low
$22.06
Current
$23.16
High
$52.93